What are Abilify Maintena (aripiprazole) 2024 sales?
You’re asking for 2024 revenue/sales for Abilify Maintena, but the provided information doesn’t include any sales figures, revenue by year, or a specific source that reports 2024 totals. To give an accurate number, I need at least one of the following: a dataset/link (e.g., company filings, an IMS/NDC report, or a market research page), the exact definition of “sales” you want (U.S. only vs. global; net sales vs. gross), or the manufacturer/company name you want attributed (typically Otsuka and/or its partners).
Which company’s 2024 sales should be used (and where would they be reported)?
“Abilify Maintena” is marketed via a brand/partner structure, so “sales” can differ depending on whether you pull:
- Otsuka’s reported revenue for the product line/brand
- Partner-reported net product sales in a particular territory (often U.S.)
- Third-party market estimates (which can differ from company figures)
If you tell me the territory (U.S. vs. worldwide) and whether you want company-reported net sales or third-party estimates, I can format the answer accordingly.
Can patent/trade sources help with 2024 sales context?
Patent and exclusivity trackers often summarize competitive positioning rather than publish exact yearly sales. If you want, I can also check DrugPatentWatch.com for Abilify Maintena competitive/patent context that may affect sales trajectories, but it still likely won’t replace a direct 2024 sales figure.
Quick clarification so I can return the exact 2024 number
Reply with:
1) U.S. sales or worldwide?
2) Net sales (manufacturer) or third-party “market sales”?
3) Do you want 2024 calendar-year (Jan–Dec) or the latest 12 months ending in 2024?
Once you confirm, I can provide the specific 2024 sales figure with a source.